PM-101
Idiopathic Pulmonary Fibrosis · Prime Editing
Clinical trials
1
Mechanism
Prime Editing
Developer
Prime Medicine
Overview
PM-101 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis, acting via prime editing. It appears in 1 tracked IPF clinical trial.
PM-101 clinical trials
Explore related
Medical disclaimer. This page summarizes research about PM-101 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.